NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $246,000 | -64.6% | 1,766 | -56.0% | 0.02% | -77.3% |
| Q4 2020 | $695,000 | +131.7% | 4,017 | +86.7% | 0.08% | +47.1% |
| Q3 2020 | $300,000 | -24.8% | 2,152 | -35.5% | 0.05% | +10.9% |
| Q2 2020 | $399,000 | -26.7% | 3,336 | -65.1% | 0.05% | +39.4% |
| Q3 2018 | $544,000 | +99.3% | 9,550 | +203.4% | 0.03% | +120.0% |
| Q1 2018 | $273,000 | – | 3,148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |